Literature DB >> 7972039

Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

Y C Liu1, T Nakano, C Elly, K Ishizaka.   

Abstract

Secretion of bioactive glycosylation-inhibiting factor (GIF) appears to be restricted to suppressor T (Ts) cells, although various human and murine cell line cells secrete the 13-kDa peptide that reacts with anti-GIF. Nucleotide sequences of GIF cDNA from the Ts and non-Ts cells are identical, indicating that bioactive GIF and inactive GIF have an identical amino acid sequence. A stable transfectant of human GIF (hGIF) cDNA in BMT10 cells secretes inactive GIF peptide, whereas transfection of a chimeric cDNA encoding a fusion protein consisting of the N-terminal region of procalcitonin precursor and hGIF into the same cells results in secretion of bioactive GIF. Evidence was obtained that the fusion protein goes into the endoplasmic reticulum and is cleaved for the secretion of mature GIF peptide, whereas the inactive 13-kDa peptide synthesized by the former transfectant does not go through the endoplasmic reticulum. However, a stable transfectant of hGIF cDNA in mouse Ts hybridoma contains inactive GIF in the cytosol and secretes bioactive hGIF without participation of the endoplasmic reticulum-Golgi system. Heterogeneity of the 13-kDa hGIF from the transfectant was detected in two-dimensional electrophoresis. The results suggested that Ts cells have a machinery that converts a portion of inactive cytosolic GIF peptide to bioactive GIF during secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972039      PMCID: PMC45200          DOI: 10.1073/pnas.91.23.11227

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  pEF-BOS, a powerful mammalian expression vector.

Authors:  S Mizushima; S Nagata
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

Review 2.  Protein folding in the cell.

Authors:  M J Gething; J Sambrook
Journal:  Nature       Date:  1992-01-02       Impact factor: 49.962

Review 3.  A novel pathway for secretory proteins?

Authors:  A Muesch; E Hartmann; K Rohde; A Rubartelli; R Sitia; T A Rapoport
Journal:  Trends Biochem Sci       Date:  1990-03       Impact factor: 13.807

4.  Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function.

Authors:  M Collins; V K Kuchroo; M J Whitters; R M O'Hara; K Kelleher; R T Kubo; M E Dorf
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Authors:  J Kandel; E Bossy-Wetzel; F Radvanyi; M Klagsbrun; J Folkman; D Hanahan
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

6.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Biochemical characterization of murine glycosylation-inhibiting factor.

Authors:  Y Tagaya; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.

Authors:  P Thomas; H Gomi; T Takeuchi; C Carini; Y Tagaya; K Ishizaka
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

9.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

10.  Growth factor-induced delayed early response genes.

Authors:  A Lanahan; J B Williams; L K Sanders; D Nathans
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

View more
  8 in total

1.  Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Authors:  Y Ishii; T Nakano; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Cloning and mapping of the mouse glycosylation-inhibiting factor gene and four related genes.

Authors:  N Honma; Y Matsuda; Y Ishii; M Sato; T Tomura; N Yuyama; T Mikayama
Journal:  Mamm Genome       Date:  1996-01       Impact factor: 2.957

3.  High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.

Authors:  K Sugie; T Nakano; T Tomura; K Takakura; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.

Authors:  H Watarai; R Nozawa; A Tokunaga; N Yuyama; M Tomas; A Hinohara; K Ishizaka; Y Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.

Authors:  T Nakano; H Watarai; Y C Liu; Y Oyama; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

6.  Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.

Authors:  T Nakano; Y C Liu; T Mikayama; H Watarai; M Taniguchi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

7.  The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.

Authors:  Y Kato; T Muto; T Tomura; H Tsumura; H Watarai; T Mikayama; K Ishizaka; R Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 8.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.